Share on StockTwits

BioSpecifics Technologies Corp. (NASDAQ:BSTC) Insider Jeffrey Kenneth Vogel sold 88,329 shares of BioSpecifics Technologies Corp. stock on the open market in a transaction dated Friday, June 20th. The shares were sold at an average price of $27.43, for a total value of $2,422,864.47. The sale was disclosed in a legal filing with the SEC, which is available at this link.

BioSpecifics Technologies Corp. (NASDAQ:BSTC) traded down 0.22% during mid-day trading on Monday, hitting $27.79. 12,696 shares of the company’s stock traded hands. BioSpecifics Technologies Corp. has a one year low of $15.59 and a one year high of $28.45. The stock has a 50-day moving average of $26.58 and a 200-day moving average of $24.45. The company has a market cap of $177.7 million and a P/E ratio of 41.02.

BioSpecifics Technologies Corp. (NASDAQ:BSTC) last released its earnings data on Thursday, May 8th. The company reported $0.12 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.07 by $0.05. The company had revenue of $2.80 million for the quarter, compared to the consensus estimate of $2.46 million. On average, analysts predict that BioSpecifics Technologies Corp. will post $0.63 earnings per share for the current fiscal year.

BioSpecifics Technologies Corp. (NASDAQ:BSTC) is a biopharmaceutical company involved in the development of an injectable collagenase for multiple indications.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.